243 related articles for article (PubMed ID: 19540252)
1. Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy.
Blair RE; Deshpande LS; Sombati S; Elphick MR; Martin BR; DeLorenzo RJ
Neuropharmacology; 2009 Sep; 57(3):208-18. PubMed ID: 19540252
[TBL] [Abstract][Full Text] [Related]
2. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus.
Blair RE; Deshpande LS; Sombati S; Falenski KW; Martin BR; DeLorenzo RJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1072-8. PubMed ID: 16469864
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.
Deshpande LS; Sombati S; Blair RE; Carter DS; Martin BR; DeLorenzo RJ
Neurosci Lett; 2007 Jan; 411(1):11-6. PubMed ID: 17110038
[TBL] [Abstract][Full Text] [Related]
4. Prolonged cannabinoid exposure alters GABA(A) receptor mediated synaptic function in cultured hippocampal neurons.
Deshpande LS; Blair RE; DeLorenzo RJ
Exp Neurol; 2011 Jun; 229(2):264-73. PubMed ID: 21324315
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
Hájos N; Katona I; Naiem SS; MacKie K; Ledent C; Mody I; Freund TF
Eur J Neurosci; 2000 Sep; 12(9):3239-49. PubMed ID: 10998107
[TBL] [Abstract][Full Text] [Related]
6. CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex.
Cass DK; Flores-Barrera E; Thomases DR; Vital WF; Caballero A; Tseng KY
Mol Psychiatry; 2014 May; 19(5):536-43. PubMed ID: 24589887
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.
Ohno-Shosaku T; Tsubokawa H; Mizushima I; Yoneda N; Zimmer A; Kano M
J Neurosci; 2002 May; 22(10):3864-72. PubMed ID: 12019305
[TBL] [Abstract][Full Text] [Related]
8. Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy.
Falenski KW; Blair RE; Sim-Selley LJ; Martin BR; DeLorenzo RJ
Neuroscience; 2007 May; 146(3):1232-44. PubMed ID: 17433556
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release.
Földy C; Neu A; Jones MV; Soltesz I
J Neurosci; 2006 Feb; 26(5):1465-9. PubMed ID: 16452670
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activation of CB1 receptor modulates long term potentiation by interfering with protein synthesis.
Navakkode S; Korte M
Neuropharmacology; 2014 Apr; 79():525-33. PubMed ID: 24412673
[TBL] [Abstract][Full Text] [Related]
11. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
Hájos N; Ledent C; Freund TF
Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
[TBL] [Abstract][Full Text] [Related]
12. Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus.
Deshpande LS; Blair RE; Nagarkatti N; Sombati S; Martin BR; DeLorenzo RJ
Exp Neurol; 2007 Apr; 204(2):705-13. PubMed ID: 17289026
[TBL] [Abstract][Full Text] [Related]
13. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus.
Hoffman AF; Riegel AC; Lupica CR
Eur J Neurosci; 2003 Aug; 18(3):524-34. PubMed ID: 12911748
[TBL] [Abstract][Full Text] [Related]
14. Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement.
Spyridakos D; Papadogkonaki S; Dionysopoulou S; Mastrodimou N; Polioudaki H; Thermos K
Neurochem Int; 2021 Jan; 142():104907. PubMed ID: 33220388
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
16. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
Kawamura Y; Fukaya M; Maejima T; Yoshida T; Miura E; Watanabe M; Ohno-Shosaku T; Kano M
J Neurosci; 2006 Mar; 26(11):2991-3001. PubMed ID: 16540577
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.
Fanarioti E; Mavrikaki M; Panagis G; Mitsacos A; Nomikos GG; Giompres P
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522428
[TBL] [Abstract][Full Text] [Related]
18. The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus in rats.
Suleymanova EM; Shangaraeva VA; van Rijn CM; Vinogradova LV
Neuroscience; 2016 Oct; 334():191-200. PubMed ID: 27520083
[TBL] [Abstract][Full Text] [Related]
19. Inverse relationship of cannabimimetic (R+)WIN 55, 212 on behavior and seizure threshold during the juvenile period.
Rudenko V; Rafiuddin A; Leheste JR; Friedman LK
Pharmacol Biochem Behav; 2012 Jan; 100(3):474-84. PubMed ID: 22019959
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
